Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.
Farmington police have identified a 51-year-old man from Pueblo, Colorado, as the victim in an aggravated battery case ...
Sharp Services, a provider of pharmaceutical packaging, clinical trial services and sterile manufacturing, is investing $100 million across its global facility network. With six GMP facilities in the ...
The FDA has issued another complete response letter (CRL) to Regeneron, rejecting its bid for approval of its prefilled syringe version of high-dose (HD) Eylea—again for unresolved issues at the ...
Despite the rejection, analysts saw Regeneron’s use of an alternate filler for Eylea HD as a positive development, with BMO Capital Markets noting that this could signal the end of manufacturing ...
The procedure’s punishing price tag, even for many with insurance, has led thousands of patients to try money-saving hacks.
Kemwell Biopharma’s Bengaluru facility earns U.S. FDA approval for commercial biologics manufacturing, expanding India’s global CDMO footprint.
Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024Dupixent® global net sales(recorded by Sanofi) increased 27% ...
Kemwell’s FDA-approved site features single-use and stainless-steel bioreactors, with over 5000L+ of installed upstream capacity, commercial fill-finish lines for liquid and lyophilized vials, and pre ...
With the safePICO self-fill blood gas syringe, you can improve your mixing and get results you can trust. Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood ...
Everyday Health on MSN
Are Compounded GLP-1 Weight Loss Drugs Really Banned?
Custom formulations of popular weight loss medications have surged in popularity due to shortages and high costs. Here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback